Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 21, 2015 08:00 ET | Source: Atossa Genetics, Inc.

Atossa Genetics Announces FDA Acceptance of Its Investigational New Drug Application to Begin a Phase II Clinical Trial of Fulvestrant for the Treatment of DCIS

SEATTLE, WA--(Marketwired - Sep 21, 2015) - Atossa Genetics Inc. (NASDAQ: ATOS), a healthcare company focused on improving breast health through the development of pharmaceuticals to treat breast...
September 08, 2015 08:00 ET | Source: Atossa Genetics, Inc.

Atossa Genetics Receives Approval to Begin Clinical Study in Israel

SEATTLE, WA--(Marketwired - Sep 8, 2015) - Atossa Genetics (NASDAQ: ATOS), a healthcare company focused on improving breast health through the development of pharmaceuticals to treat breast health...
September 04, 2015 08:00 ET | Source: Atossa Genetics, Inc.

Atossa Genetics Inc. to Present at the Rodman & Renshaw 17th Annual Global Investment Conference

SEATTLE, WA--(Marketwired - Sep 4, 2015) - Atossa Genetics Inc. (NASDAQ: ATOS), a healthcare company focused on improving breast health through the development of pharmaceuticals to treat breast...
September 02, 2015 08:00 ET | Source: Atossa Genetics, Inc.

Atossa Genetics, Inc. Announces Appointment of Scott Youmans as Chief Operating Officer

SEATTLE, WA--(Marketwired - Sep 2, 2015) - Atossa Genetics, Inc. (NASDAQ: ATOS), a healthcare company focused on improving breast health through the development of pharmaceuticals to treat breast...
August 06, 2015 16:01 ET | Source: Atossa Genetics, Inc.

Atossa Genetics Announces Second Quarter 2015 Financial Results and Provides Company Update; Achieves Total Revenue for Q2 2015 of $2.7 Million

SEATTLE, WA--(Marketwired - Aug 6, 2015) - Atossa Genetics Inc. (NASDAQ: ATOS) today announced second quarter 2015 financial results and provided an update on recent company...
August 05, 2015 11:00 ET | Source: Atossa Genetics, Inc.

Atossa Genetics to Announce Second Quarter 2015 Financial Results and Provide a Company Update on Thursday, August 6, 2015

SEATTLE, WA--(Marketwired - Aug 5, 2015) - Atossa Genetics, Inc. (NASDAQ: ATOS) announced today that it will issue financial results and corporate developments for the Second Quarter ended June 30,...
August 05, 2015 08:00 ET | Source: Atossa Genetics, Inc.

Atossa Genetics and AAIPharma / Cambridge Major Laboratories Announce Manufacturing Agreement for Atossa's Lead Drug Candidate Afimoxifene Gel

SEATTLE, WA--(Marketwired - Aug 5, 2015) - Atossa Genetics Inc. (NASDAQ: ATOS), the Breast Health Company, announced today that it has signed manufacturing and quality agreements with AAIPharma...
July 22, 2015 08:00 ET | Source: Atossa Genetics, Inc.

Atossa Genetics Subsidiary The NRLBH Now Provides Enhanced Pharmacogenetic Test Based on Luminex xTAG Platform

SEATTLE, WA--(Marketwired - Jul 22, 2015) - Atossa Genetics Inc. (NASDAQ: ATOS) today announced that its subsidiary, The National Reference Laboratory for Breast Health Inc. (the NRLBH), now...
July 01, 2015 08:00 ET | Source: Atossa Genetics, Inc.

Atossa Genetics Announces Acquisition of Ductal Lavage Specimen Bank From the Dr. Susan Love Research Foundation

SEATTLE, WA--(Marketwired - Jul 1, 2015) - Atossa Genetics Inc. (NASDAQ: ATOS), the Breast Health Company, announced today that it has acquired a specimen bank from Dr. Susan Love Research...
June 11, 2015 08:00 ET | Source: Atossa Genetics, Inc.

Atossa Genetics Announces Issuance of Patent US9,052,318 by the U.S. Patent and Trademark for Breast Cancer Detection Using Absorbent Paper

SEATTLE, WA--(Marketwired - Jun 11, 2015) - Atossa Genetics Inc. (NASDAQ: ATOS), the Breast Health Company, announced today that the U.S. Patent and Trademark Office has issued a new patent, Serial...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right